London
· Delayed Price · Currency is GBP · Price in USD QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of GBP 2.15 billion. The enterprise value is 4.17 billion.
| Market Cap | 2.15B |
| Enterprise Value | 4.17B |
Important Dates
The last earnings date was Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 60.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.59 |
| EV / Sales | 1.89 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 115.14 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.88.
| Current Ratio | 1.22 |
| Quick Ratio | 0.38 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 4.84 |
| Debt / FCF | n/a |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -50.58% and return on invested capital (ROIC) is 0.43%.
| Return on Equity (ROE) | -50.58% |
| Return on Assets (ROA) | 0.38% |
| Return on Invested Capital (ROIC) | 0.43% |
| Return on Capital Employed (ROCE) | 0.84% |
| Revenue Per Employee | 311,312 |
| Profits Per Employee | -226,753 |
| Employee Count | 7,100 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.01% |
| 50-Day Moving Average | 42.22 |
| 200-Day Moving Average | 41.20 |
| Relative Strength Index (RSI) | 49.59 |
| Average Volume (20 Days) | 177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.74 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of GBP 2.21 billion and -1.61 billion in losses. Loss per share was -23.96.
| Revenue | 2.21B |
| Gross Profit | 1.02B |
| Operating Income | 36.38M |
| Pretax Income | -1.69B |
| Net Income | -1.61B |
| EBITDA | 396.49M |
| EBIT | 36.38M |
| Loss Per Share | -23.96 |
Balance Sheet
The company has 78.07 million in cash and 2.11 billion in debt, giving a net cash position of -2.03 billion.
| Cash & Cash Equivalents | 78.07M |
| Total Debt | 2.11B |
| Net Cash | -2.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.39B |
| Book Value Per Share | 35.52 |
| Working Capital | 174.81M |
Cash Flow
| Operating Cash Flow | 65.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.23%, with operating and profit margins of 1.65% and -72.84%.
| Gross Margin | 46.23% |
| Operating Margin | 1.65% |
| Pretax Margin | -76.59% |
| Profit Margin | -72.84% |
| EBITDA Margin | 17.94% |
| EBIT Margin | 1.65% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.60% |
| Shareholder Yield | -0.60% |
| Earnings Yield | -74.79% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |